Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1978 1
1980 1
1989 3
1990 1
1992 1
1993 2
1996 2
2000 1
2002 1
2004 4
2008 1
2009 1
2010 2
2011 3
2013 2
2015 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Gallstone-dissolving agents
Peine CJ. Gastroenterol Clin North Am 1992 - Review. PMID 1516964
Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate.
Sulkowski MS, et al. Gastroenterology 2010 - Clinical Trial. PMID 20723545
BACKGROUND & AIMS: Hepatitis C virus (HCV) treatment is frequently complicated by anemia from ribavirin (RBV)-related hemolysis and peginterferon-alfa (PEG-IFN)-related bone marrow suppression. ...
BACKGROUND & AIMS: Hepatitis C virus (HCV) treatment is frequently complicated by anemia from ribavirin (RBV)-related hemolysis a …
High-dose vitamin E supplementation does not diminish ribavirin-associated haemolysis in hepatitis C treatment with combination standard alpha-interferon and ribavirin.
Saeian K, et al. Aliment Pharmacol Ther 2004 - Clinical Trial. Among authors: Peine C. PMID 15569122 Free article.
AIM: To determine effect of vitamin E supplementation on ribavirin-associated haemolysis in chronic hepatitis C treated with standard alpha-interferon and ribavirin. METHODS: Fifty-one naive chronic hepatitis C patients were randomized to receive either alpha-interferon/ribavirin therapy (control) or therapy plus vitamin E 800 IU b.d. with 24-week follow-up. ...
AIM: To determine effect of vitamin E supplementation on ribavirin-associated haemolysis in chronic hepatitis C treated with standard …
Racial differences in hepatitis C treatment eligibility.
Melia MT, et al. Hepatology 2011. PMID 21488082 Free PMC article.
Black Americans are disproportionally infected with hepatitis C virus (HCV) and are less likely than whites to respond to treatment with peginterferon (PEG-IFN) plus ribavirin (RBV). ...
Black Americans are disproportionally infected with hepatitis C virus (HCV) and are less likely than whites to respond to treatment w …
Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.
Poordad F, et al. Gastroenterology 2013 - Clinical Trial. PMID 23924660
BACKGROUND & AIMS: Treatment of hepatitis C virus (HCV) infection with boceprevir, peginterferon, and ribavirin can lead to anemia, which has been managed by reducing ribavirin dose and/or erythropoietin therapy. ...
BACKGROUND & AIMS: Treatment of hepatitis C virus (HCV) infection with boceprevir, peginterferon, and ribavirin can lead to anemi …
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.
McHutchison JG, et al. N Engl J Med 2009 - Clinical Trial. PMID 19625712 Free article.
BACKGROUND: Treatment guidelines recommend the use of peginterferon alfa-2b or peginterferon alfa-2a in combination with ribavirin for chronic hepatitis C virus (HCV) infection. ...
BACKGROUND: Treatment guidelines recommend the use of peginterferon alfa-2b or peginterferon alfa-2a in combination with ribavirin for chron …
A randomized trial of Chinese herbal medicines for the treatment of symptomatic hepatitis C.
Jakkula M, et al. Arch Intern Med 2004 - Clinical Trial. Among authors: Peine CJ. PMID 15226169
BACKGROUND: Many patients with the hepatitis C virus (HCV) cannot be successfully treated with interferon-based regimens. Chinese herbal medicines have been widely prescribed for HCV in Asia, and many infected patients in the United States have used these agents. ...
BACKGROUND: Many patients with the hepatitis C virus (HCV) cannot be successfully treated with interferon-based regimens. Chinese her …
28 results
Jump to page
Feedback